Yahoo Web Search

Search results

1. Kymera Therapeutics, Inc.

   NasdaqGM: KYMR

   34.05

   Add to watchlist

   Sign in to add to watchlist

   Sign In

   -0.19 (-0.55%)

   At close: Fri. May 24, 2024 4:00 PM EDT · Nasdaq Real Time Price (USD) · Market closed

   Full chart

   • 1D
   • 5D
   • 1M
   • 6M
   • YTD
   • 1Y
   • MAX

   • Open	34.38
     High	36.00
     Low	33.94

   • Mkt Cap	2.09B
     P/E (TTM)	N/A
     Div & Yield	N/A & N/A

   • Prev. Close	34.24
     52 Wk. Low	9.60
     52 Wk. High	45.31

   More about KYMR

   Top stories

   • KYMR
     -0.55%

   Kymera Therapeutics, Inc. (NASDAQ:KYMR) Just Released Its First-Quarter Earnings: Here's What Analysts Think

   Yahoo Finance · 3 weeks ago

   

   • LGND
     +1.75%
   • KYMR
     -0.55%
   • BMRN
     -0.50%
   • IMVT
   • BPMC

   Zacks Industry Outlook Highlights BioMarin, Blueprint Medicines, Immunovant, Kymera and Ligand

   Yahoo Finance · 3 weeks ago

   

   Related stocks

   • NRIX
     Nurix Therapeutics, Inc.
     NRIX
     15.17
     0.00%
   • RLAY
     Relay Therapeutics, Inc.
     RLAY
     6.82
     -2.29%
   • CCCC
     C4 Therapeutics, Inc.
     CCCC
     5.48
     -1.62%
   • RVMD
     Revolution Medicines, Inc.
     RVMD
     37.95
     -0.47%
   • ITOS
     iTeos Therapeutics, Inc.
     ITOS
     17.68
     +0.80%

   More on Yahoo Finance

2. finance.yahoo.com › quote › KYMRKymera Therapeutics, Inc. (KYMR) Stock Price, News, Quote ...

   finance.yahoo.com › quote › KYMR

   • Cached

   SWTXSpringWorks Therapeutics, Inc. 42.81. -3.30%. Find the latest Kymera Therapeutics, Inc. (KYMR) stock quote, history, news and other vital information to help you with your stock trading and ...

3. www.kymeratx.comRevolutionary Medicines Catalyzed by Protein Degradation ...

   www.kymeratx.com

   • Cached

   Kymera is a biotech company that develops medicines using targeted protein degradation, a novel modality that can address a wide range of diseases. Learn more about Kymera's pipeline, team, and vision to reinvent medicine.

4. investors.kymeratx.comKymera Overview | Kymera Therapeutics, Inc.

   investors.kymeratx.com

   • Cached

   May 2, 2024 · Kymera is a biopharmaceutical company developing small molecule drugs that degrade disease-causing proteins. Find stock information, events, presentations, press releases, filings, and more on this website.

5. www.google.com › finance › quoteKymera Therapeutics Inc (KYMR) Stock Price & News - Google ...

   www.google.com › finance › quote

   • Cached

   Get the latest Kymera Therapeutics Inc (KYMR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

6. www.marketwatch.com › investing › stockKYMR Stock Price | Kymera Therapeutics Inc. Stock Quote (U.S ...

   www.marketwatch.com › investing › stock

   May 2, 2024 · KYMR is the ticker symbol for Kymera Therapeutics Inc., a biotech company developing protein degradation therapies. Get the latest stock price, earnings, analyst ratings, news and more on MarketWatch.

   • 1 Month: 15.43%
   • 5 Day: 3.22%

   • 3 Month: 25.26%
   • YTD: 35.25%

7. Images

   • 
   • 
   • 
   • 

   View all

8. investors.kymeratx.com › news-events › press-releasesPress Releases | Kymera Therapeutics, Inc.

   investors.kymeratx.com › news-events › press-releases

   • Cached

   Kymera Therapeutics is a biopharmaceutical company developing small molecule medicines using targeted protein degradation. Read the latest news on its immunology and oncology programs, financial results, and public offerings.

9. finance.yahoo.com › quote › KYMRKymera Therapeutics, Inc. (KYMR) Latest Stock News ...

   finance.yahoo.com › quote › KYMR

   • Cached

   WATERTOWN, Mass., April 25, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using ...